Introduction
Epileptic seizures are a frequent clinical manifestation of cerebral malignant (high grade) glioma. [1] [2] [3] Actually, the large majority of patients with new-onset neurologic symptoms related to this malignancy are identified by radiologic evidence of necrotic masses with rim-contrast enhancement and perilesional oedema. These neuroimaging findings are usually associated with an unfavourable prognosis quoad vitam in the short term, as the median survival time of patients with high grade glioma, even after surgery, radiotherapy and chemotherapy, is approximately 22 months for anaplastic astrocytoma and 12 months for glioblastoma. 4 In a subgroup of patients, however, the clinical presentation of malignant glioma might coincide with the very early stage of the tumoural process in the event that neuroimaging studies indicate minimal non-enhancing brain abnormalities or even fail to reveal any sign of the tumour. 5, 6 In this case, the diagnosis of glioma can be easily missed, with significant consequences for the patient's prognosis. Conventional magnetic resonance imaging (MRI) has significantly improved the visualisation of small non-enhancing brain tumours, that might not be detectable with computed tomography (CT). Further, the development of diffusion-weighted (DWI) and perfusion-weighted imaging (PWI) has made it possible to investigate specific anatomoradiologic features of gliomas, such as cellularity and vascularity, which have recently been proposed as predictors of tumour grade. [7] [8] [9] [10] [11] Metabolic studies with positron emission tomography (PET) have also demonstrated a pathogenic relationship between radio-marked glucose and amino acid uptake and grading. 12, 13 Despite the increasing amount of information obtained from neuroimaging of brain tumours, early-stage high grade gliomas lack specific radiologic characteristics and timely identification of these malignancies remains challenging.
Materials and methods
We reviewed the clinical, EEG and neuroimaging findings from three adult patients (a 75-year-old man and two women, aged 58 and 68, respectively), who presented to the hospital with newonset seizure disorders as early clinical manifestations of de novo high grade gliomas. Plain and gadolinium-enhanced MRI of the brain was performed on all patients, using a 1-Tesla MRI system. Two patients also underwent a brain CT scan without contrast material. Diagnosis of gliomas could not be made at the time of the first epileptic seizure because of minimal non-specific brain abnormalities that did not show signs of necrosis or significant contrast enhancement on the imaging studies. All patients were discharged from the hospital with normal neurological status but We report the clinical, EEG and neuroradiologic findings from three adult patients who developed newonset seizure disorders as early clinical manifestations of de novo high grade glioma. The malignancies could not be recognised at the time of the first epileptic seizure because of minimal non-specific brain abnormalities, which showed no signs of necrosis or significant contrast enhancement on computed tomography and magnetic resonance imaging. Focal EEG abnormalities were recorded in all cases and appeared consistent with the neuroradiologic findings. The patients regained normal neurological status after the first seizure but rapidly developed space-occupying necrotic lesions. Two patients underwent surgery and received histological diagnoses of the tumours. Another patient was finally diagnosed with a malignant glioma based on the neuroradiologic picture and rapid progression of the cerebral lesion. It should be noted that in adult patients, new-onset epileptic seizures might reveal the presence of malignant gliomas at a very early stage in the tumour formation process. This report indicates that typical anatomoradiologic features of de novo high grade glioma, such as necrosis and rim-contrast enhancement, could be absent at the time of the first epileptic seizure but become clear within a short period after clinical presentation.
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rapidly developed necrotic masses. Histological diagnoses of the tumours were obtained after surgery in two cases. In the other case, the malignant glioma was finally diagnosed using the neuroradiologic picture and rapid progression of the cerebral lesion.
Results
The seizure type, EEG and neuroimaging findings are summarised in Table 1 . In all cases, new-onset epileptic seizures heralded the clinical manifestation of the malignancies. A generalised tonic-clonic seizure (GTCS) was firstly reported in one patient, who also developed abrupt confusion with speech disturbances, and subsequent right hemiclonic seizure 3 weeks later. In this case, mental and speech function returned to normal after 5 days. Acute mental abnormalities in the form of spatial disorientation associated with speech deficit, followed by a GTCS were also described as initial symptoms in one of the other cases. Another patient presented with abrupt impairment of consciousness, leftward deviation of the head and trunk, and subsequently fell to the ground. All patients regained normal neurological status after the first seizure, without recalling the epileptic symptomatology.
In two cases, brain CT scans without contrast material revealed a small hyperdense abnormality with mild peripheral hypodensity in the left lateral temporal region ( Fig. 1a and b ) and temporoparieto-occipital (TPO) crossway (not shown), respectively. In one of these cases, such abnormality was triangular in shape, and mimicked a haemorrhagic infarction (Fig. 1b) .
In all patients, the MRI revealed indistinct areas of signal hyperintensity on T2-weighted, fluid-attenuated inversion recovery (FLAIR) and proton density (PD) images (Figs. 2a-c, 3a-c, and 4a-c) with similar distribution to that seen on the CT scans in two cases. T1-weighted MRI did not provide significant information, with the exception of a tiny spot of signal hypointensity that was observed in the right middle temporal gyrus of one patient (Fig. 3c) . A gyral swelling was detected in two cases. This feature was best visualised on FLAIR and PD images, the latter demonstrating the major involvement of the cortex (Fig. 2b) . The administration of gadolinium did not enhance the abnormalities seen in two patients, while there was evidence of a tiny nodular contrast enhancement in the left TPO crossway in the other case (Fig. 4c) .
Focal EEG abnormalities including periodic lateralised epileptiform discharges (PLEDs), sharp waves (SW) and theta-delta slowing, were reported for all patients and appeared consistent with the neuroimaging findings. The EEG abnormalities were recorded after full recovery from ictal symptoms, with the exception of PLEDs, which were detected before the regression of the state of confusion with speech disturbances. In this case, PLEDs were no longer present, as they were replaced by irregular theta-delta activity on another EEG recorded 5 days after the onset of mental and speech disorders, when the patient was already asymptomatic.
In two cases, subsequent MRI examinations indicated enhancing space-occupying lesions (Figs. 3d and 4d) 2 months after the first seizure when both patients still showed normal neurological status. The histopathology of tumours, according to the classification of the World Health Organization, 14 was obtained after surgery and revealed a grade III anaplastic oligodendroglioma and a glioblastoma, respectively. Another patient came back to the (4) Glioblastoma (left TPO crossway) Fig. 1. (a and b) Plain CT scan performed after the first seizure: hyperdense lesion with marginal hypodensity, mimicking a haemorrhagic infarction in the left temporal lobe.
hospital 3 months after the first seizure, when he started to show progressive speech deficits. Subsequent MRI studies revealed a left temporal necrotic mass with irregular contrast enhancement and perilesional oedema that appeared consistent with glioblastoma (Fig. 2d) . In this case, the initial CT (Fig. 1a and b ) and MRI findings (Fig. 2a-c) had previously resulted unchanged in a second neuroimaging study that was performed 2 months after the first seizure. This patient refused surgery and died of tumour progression shortly after the radiologic diagnosis of malignant glioma. The patients who were operated on showed relapses of the malignancies and died 1 year after surgery.
Discussion
These results illustrated the clinical, EEG and neuroimaging characteristics of seizures related to cerebral malignant gliomas at a very early stage of tumoural growth and documented the neuroradiologic progression of the malignancies from minimal, non-specific, brain abnormalities to more consistent radiologic features. It is known that high grade gliomas can develop as de novo lesions or derive from the secondary transformation of low grade tumours. 15, 16 In the latter case, the anaplastic transformation usually occurs after a variable period of years, 15 when patients have already become symptomatic and the low grade lesion has been identified. 16 Different from such anatomoclinical course, the rapid progression of small cerebral abnormalities during a period of few weeks in these patients indicated that these malignancies arose as de novo high grade lesions. These findings are in agreement with previous reports, which demonstrated that de novo high grade gliomas could result from non-enhancing abnormalities and rapidly develop into necrotic masses with rim-contrast enhancement. 6, 17 Despite the major incidence of epileptic disorders in patients with low grade gliomas, 1, 3, 18, 19 seizures are a distinctive clinical manifestation of early-stage high grade tumours. 5, 6, 17 In these patients, seizures were similarly related to localisations of glioma in the lateral temporal region, with additional participation of the TPO crossway in one case where neuroimaging indicated major involvement of the cortex. While it has not been demonstrated that early clinical presentation of cerebral tumours corresponds to specific brain localisations, it is reasonable that the tumoural infiltration of the cortex may result in earlier onset of symptoms, particularly seizures 2, 20 and possibly focal neurologic deficits, if the malignancy develops in eloquent areas of the brain. Localisations in the cortico-medullary junction actually predominated in a series of patients with small gliomas, 21 while a superficial tumoural origin has been described in cases of glioblastoma with early clinical presentation. 22 Further, the cortical involvement on the lateral surface of the brain could explain the timely expression of significant EEG abnormalities, regardless of the small size of lesions. Particularly for the patients who developed acute mental abnormalities and speech disturbances, the EEG provided important clues about the site of lesion, indicating a symptomatic epileptic localisation in the left temporal region. In one of these patients, the prolonged alteration of speech and mental function could be entirely attributed to the presence of PLEDs, an ictal EEG pattern that has already been reported in patients with confusion of epileptic origin. 23 In fact, the regression of neurologic symptoms coincided with the disappearance of this EEG pattern, despite the underlying parenchymal lesion. Although the ictal EEG could not be recorded for another patient who exhibited similar alterations in mental and speech function with consequent GTCS, the clinical and EEG findings equally suggested a focal seizure disorder, with major disturbance of the left temporal lobe and secondary generalisation. In this case, mental status and speech returned to normal rapidly after the seizure, when the EEG recorded interictal abnormalities in the form of focal theta slowing and SW. Our findings indicated that confused mental states with disturbances of speech might characterise the symptomatology of seizure disorders related to localisation of malignant glioma in the lateral temporal region of the dominant hemisphere. In this case, PLEDs could be recorded during the ictal period and occasionally be responsible for prolonged alteration of mental and speech function. MRI is considered more sensitive than CT in detecting small nonenhancing cerebral tumours. 5 In this regard, it is notable that parenchymal abnormalities with similar radiologic characteristics could be identified with CT in two patients. Apart from the peripheral hypodensity of these lesions that might be attributed to mild oedema, the interpretation of the hyperdense appearance of the gliomas on CT remains uncertain. Cerebral lesions with hyperdense characteristics on plain CT usually correspond to calcification or haemorrhagic damage. Although the use of MRI might be less valuable in these circumstances, the overall MRI results could not confirm any of these types of parenchymal damage. In fact, areas with absence of signal or significant hypointensity on T1 and T2-weighted images (as in the case of calcification) or hyperintensity on T1-weighted images usually observed during the follow-up of haemorrhagic lesions, were not reported for the patients that underwent both CT and MRI. An increased cellularity and vascularisation of the tumoural lesion due to the high grading of glioma could explain the manifestation of hyperdense abnormalities on plain CT scans. Anatomical characteristics of these initial lesions, however, cannot be demonstrated without histological data or additional information from more advanced neuroradiologic techniques such as perfusion-CT, 24 DWI, and PWI. [7] [8] [9] [10] [11] Further information is also necessary to clarify whether the hyperdense appearance of small tumoural lesions seen by plain CT might represent an early radiologic feature of glioblastoma. The MRI findings were mainly characterised by indistinct areas of signal hyperintensity on T2-weighted, FLAIR and PD images, with signs of gyral swelling in two cases. On these sequences, signal hyperintensities usually indicate increased water content in the cerebral parenchyma, a non-specific alteration that might result from brain damage of various aetiologies. Considering that oedema and the solid portion of malignant glioma cannot be clearly differentiated with any of these sequences, the exact extension of non-enhancing tumours, as in these cases, can be difficult to determine with conventional MRI. Although the radiologic borders of malignant glioma are generally referred to as rim-contrast enhancement, the neuropathology of high grade lesions demonstrated that infiltration by neoplastic cells can be found beyond these limits, in areas with T2 signal hyperintensity, 14 and even in the parenchyma free of radiologic abnormalities. 25 It is unclear to what extent such invasion of the parenchyma can occur during the early stage of malignant glioma formation. In these cases, however, the detection of radiologic abnormalities with indistinct margins (Figs. 2a and 4a) could be a sign of early aggressive behaviour of these tumours, as infiltration of the parenchyma could have preceded the development of necrosis and the disruption of the blood-brain-barrier. Plain T1-weighted MRI findings were limited to the tiny area of signal hypointensity pictured in Fig. 3c , that could be interpreted as tumoural microcyst or initial necrosis. Despite the minimal appearance of this feature, its significance as an early radiologic sign of de novo high grade glioma formation is consistent with previous findings. In fact, the development of a small, central cyst before the emergence of contrast enhancement has been demonstrated during the early stage of high grade astrocytic lesions. 26 The radiologic presentation of tumours with non-enhancing abnormalities in two of these cases reflected the substantial integrity of the blood-brain-barrier during the initial phase of the process. It has been demonstrated, however, that the maintenance of the blood-brain-barrier is usually brief in malignant glioma, as the vast majority of patients with early-stage high grade tumours developed enhancing necrotic masses within 6 months from the initial symptomatology. 5, 6, 17, 22 The information available suggests that the neuroradiologic follow-up of uncertain brain abnormalities should be carried out throughout such period on adult patients with new-onset seizure disorders.
Regarding the rapid progression of these early neoplastic lesions, we believe that neuroimaging studies should be repeated at intervals of 1 month at least during the first 3-month-period, if the tumoural aetiology of new-onset seizures cannot be excluded with additional investigations. Indeed, the radiologic changes depicted in Fig. 3 indicate that consistent imaging features can unexpectedly appear a few weeks after the discovery of tiny unremarkable abnormalities. Neuroimaging studies with DWI, PWI, PET and magnetic resonance spectroscopy, which are currently included in the diagnostic work-up of brain tumours, might provide useful information for pre-operatively determining the tumour grade. [7] [8] [9] [10] [11] 15 To our best knowledge, however, there is no evidence that these investigations effectively lead to early surgery of malignant glioma, if conventional MRI has not yet demonstrated consistent abnormalities. Although the information available is insufficient to delineate a specific clinicoradiologic profile of patients with early presentation of de novo high grade glioma, it must be stressed that new-onset seizure disorders might reveal the initial stage of this malignancy. Biopsy of indefinite brain abnormalities should be constantly considered for adult patients with newly diagnosed epileptic seizures. Nonetheless, the neuroradiologic surveillance at short intervals might be crucial for timely identification of de novo high grade glioma, with the purpose of achieving the best possible treatment and prognosis.
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